Source: U.S. News & World Report
Security & Justice
Israel Army Says Hit Over 100 'Terror Targets' in Lebanon in Past Day
The Israeli military on Wednesday said it struck more than 100 "terror targets" in Lebanon over the past day and had "eliminated" two Hezbollah commanders at the weekend.
Wednesday, November 20, 2024
Israeli Strikes Kill Four Lebanese Soldiers in Two Days, Army Reports
Israeli Strikes Kill Four Lebanese Soldiers in Two Days, Army Reports
Wednesday, November 20, 2024
Opinion
Lebanon's Economy—Not Battlefield—May Have the Final Word
Time and again during this most recent war in Lebanon, we hear the phrase, “The battlefield has the final word”. It has become the sole and wholly unsatisfactory refrain of Hezbollah and the so-called 'Axis of Resistance'.
Wednesday, November 20, 2024
Flying Above the Bombs, a Lebanese Airline Becomes an Unlikely National Hero
It used to be like almost any other national carrier, fielding gripes about flight delays, ticket prices and bad food.
Wednesday, November 20, 2024
Sports
Alcaraz Beats Rublev to Open ATP Finals Account
Carlos Alcaraz opened his account at the ATP Finals on Wednesday with an entertaining 6-3, 7-6 (10/8) win over Andrey Rublev which boosted his hopes of reaching the semifinals.
Wednesday, November 13, 2024
Ecuador's Angulo, 22, Dies a Month After Car Crash
Ecuador international Marco Angulo has died at the age of 22 just over a month after being seriously injured in a car crash, his club has announced.
Tuesday, November 12, 2024
Thursday 3 November 2022 18:47:09
Pfizer Launches Trial of Flu, COVID-19 Combination Vaccine
Pfizer on Thursday announced that the first participant in a trial to examine an influenza and COVID-19 combination vaccine has been dosed.
The early-stage trial will examine the shot’s safety, tolerability and ability to provoke an immune response, according to Pfizer and its partner BioNTech. The shot includes Pfizer’s updated COVID-19 shot that is designed to take on the omicron variant.
Annaliesa Anderson of Pfizer’s vaccine research and development said that such a shot “could simplify immunization practices against these two respiratory pathogens, potentially leading to better vaccine uptake for both diseases.”
“Even with existing seasonal influenza vaccines, the burden of this virus is severe across the world causing thousands of deaths and hospitalizations every year,” Anderson said in a statement.
The study will include 180 participants ranging from 18 to 64 years old.
“By combining both indications in one vaccine approach, we aim to provide individuals with an efficient way to receive immunization against two severe respiratory diseases with evolving viruses that require vaccine adaptation,” BioNTech CEO Ugur Sahin said in a statement.
The news comes as flu activity in the U.S. continues to increase. The first pediatric death from the flu was confirmed by the Centers for Disease Control and Prevention last week.
The CDC estimates that at least 6,900 people have been hospitalized with the flu so far this season, which is a level that hasn’t been recorded this early in the season going back over a decade.
Experts are concerned that low levels of immunity as well as the relaxation of COVID-19 mitigation measures could fuel a severe flu season as colder weather pushes more people indoors.
